Lehman Brothers UK Capital Funding IV LP: Notice to the Holders of the Preferred Securities
September 19, 2024 08:12 ET | Lehman Brothers UK Capital Funding IV LP
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- NOTICE TO THE HOLDERS OF: EUR 200,000,000 EURO FIXED RATE ENHANCED CAPITAL ADVANTAGED PREFERRED SECURITIES ("LP IV ECAPS") ISSUER: LEHMAN BROTHERS...
Lehman Brothers UK Capital Funding V LP: Notice to the Holders of the Preferred Securities
September 19, 2024 08:10 ET | Lehman Brothers UK Capital Funding V LP
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- NOTICE TO THE HOLDERS OF: USD 500,000,000 FIXED RATE ENHANCED CAPITAL ADVANTAGED PREFERRED SECURITIES ("LP V ECAPS") ISSUER: LEHMAN BROTHERS UK CAPITAL...
Lehman Brothers UK Capital Funding LP: Notice to the Holders of the Preferred Securities
September 19, 2024 08:08 ET | Lehman Brothers UK Capital Funding LP
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- NOTICE TO THE HOLDERS OF: EUR 225,000,000 FIXED RATE TO CMS-LINKED GUARANTEED NON-VOTING, NON-CUMULATIVE PERPETUAL PREFERRED SECURITIES ("LP I...
noble-logo_vertical_blu-wht (1).png
NobleAI Recognized in Gartner’s Market Guide for Materials Informatics Solutions
September 19, 2024 08:05 ET | NobleAI
Gartner Report Highlights Company’s Strength and Unique Offering in Emerging AI for Science Sector
Filevine’s LEX Summi
Filevine’s LEX Summit 2024: A Landmark Event for the Legal Industry
September 19, 2024 08:05 ET | Filevine
Salt Lake City, UT, Sept. 19, 2024 (GLOBE NEWSWIRE) --  Filevine, leading provider of legal technology, successfully concluded its celebrated user conference, LEX Summit, held at the Hyatt Regency...
32BJ Labor Industry Alliance - black lettering.png
32BJ Labor Industry Cooperation Fund Releases Interactive Tools to Help Employers and Unions Achieve Lower Hospital Prices
September 19, 2024 08:02 ET | 32BJ Labor Industry Cooperation Fund
To help purchasers/employers lower healthcare costs, the 32BJ Labor Industry Cooperation Fund released a hospital savings calculator and contract template.
eyconis_logo_color.png
Eyconis, Inc. Announces Appointment of Dr. Mark J. Bachleda as Chief Executive Officer and Member of the Board of Directors
September 19, 2024 08:00 ET | Eyconis, Inc.
REDWOOD CITY, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Eyconis, Inc., a biopharmaceutical company focused on developing novel, best-in-class therapeutics for eye diseases, today announced that...
KASKELA LAW LOGO1.jpg
Kaskela Law LLC Announces Shareholder Investigation of The Scotts Miracle-Gro Company (NYSE: SMG) and Encourages Long-Term SMG Shareholders to Contact the Firm
September 19, 2024 08:00 ET | Kaskela Law
PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating The Scotts Miracle-Gro Company (NYSE: SMG) (“Scotts”) on behalf of the company’s long-term...
01A LifeMD Teal Blue.png
LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options
September 19, 2024 08:00 ET | LifeMD, Inc.
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc.® (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced significant enhancements to its weight management...
AIMLogo.jpg
AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer
September 19, 2024 08:00 ET | AIM ImmunoTech Inc.
Preliminary finding of stable disease in two out of three patients at 6 months in the first subject cohort Combination of Ampligen and Imfinzi continues to be generally well-tolerated with no...